Drug treatments for psychiatric disorders in children have always been
a matter of controversy. During the past two decades psychopharmacolo
gists have madeconsiderable strides in establishing the efficacy and s
afety of existing drugs. Recent research has also generated new treatm
ents whose practical benefits are yet to be established. This article
presents a brief and selective overview of the current state of paedia
tric psychopharmacology.